Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Pranav Chandrashekar"'
Autor:
Morris M. Kim, Mark Prasad, Yunwoo Burton, Clinton M. Kolseth, Yuanzi Zhao, Pranav Chandrashekar, Babak Nazer, Ahmad Masri
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 15 (2023)
Background Transthyretin cardiac amyloidosis (ATTR‐CM), found in 6% to 15% of cohorts with heart failure with preserved ejection fraction, has long been considered a rare disease with poor prognosis. New treatments have made it one of the few direc
Externí odkaz:
https://doaj.org/article/06f95632625c4ce8b8fab38b29d6eb5a
Autor:
Hongya Chen, Pranav Chandrashekar, Katherine Fischer, Dayna Carlson, Urja Narayan, Jack Chen, Ahmad Masri
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 7 (2022)
Advancement in the diagnosis and treatment of transthyretin amyloid cardiomyopathy has made great strides in recent years. Novel therapeutics for transthyretin amyloidosis such as tafamidis, patisiran, and inotersen have shown significant benefits in
Externí odkaz:
https://doaj.org/article/8eb07d8352614fb28804450668add752
Autor:
Zack Dale, Pranav Chandrashekar, Lana Al-Rashdan, Sajan Gill, Miriam Elman, Katherine Fischer, Babak Nazer, Ahmad Masri
Publikováno v:
International Journal of Cardiology. 358:65-71
Atrial fibrillation and flutter (AF/AFL) are common in transthyretin cardiac amyloidosis (ATTR-CM) which in turn is associated with higher risk of thromboembolism. Detecting AF/AFL may be especially important, but the role of routine ambulatory monit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54e263bd1dc20e413354b574b4d78550
https://doi.org/10.1016/j.ijcard.2022.04.045
https://doi.org/10.1016/j.ijcard.2022.04.045
Publikováno v:
Journal of Cardiac Failure. 29:690-691
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a2fe4cd2d7492fdd20e55fab8d00b31
https://doi.org/10.1016/j.cardfail.2022.10.360
https://doi.org/10.1016/j.cardfail.2022.10.360
Publikováno v:
Heart Failure Reviews. 27:1587-1603
The therapeutic landscape for cardiac amyloidosis is rapidly evolving. In the last decade, our focus has shifted from dealing with the inevitable complications of continued extracellular infiltration of amyloid fibrils to earlier identification of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ee585ade35be138b8b8e55c1f0cc8c2
https://doi.org/10.1007/s10741-021-10180-z
https://doi.org/10.1007/s10741-021-10180-z
Autor:
Mark Prasad, Morris Kim, Pranav Chandrashekar, Yuanzi Zhao, Katherine L. Fischer, Babak Nazer, Ahmad Masri
Publikováno v:
International journal of cardiology.
Transthyretin amyloid cardiomyopathy (ATTR-CM), particularly wild type (wtATTR-CM), is thought to mainly affect men. Non-invasive diagnosis and approved therapeutics have been associated with increased disease recognition. We investigated the traject
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ba8c1728c6e9bda242f7520da1111f7
https://pubmed.ncbi.nlm.nih.gov/36587655
https://pubmed.ncbi.nlm.nih.gov/36587655
Autor:
Isabella Bustanoby, Andrew Krupien, Umaima Afifa, Benjamin Asdell, Michaela Bacani, James Boudreau, Javier Carmona, Pranav Chandrashekar, Mark Diamond, Diego Espino, Arnav Gangal, Chandan Kittur, Yaochi Li, Tanvir Mann, Christian Matamoros, Trevor McCarthy, Elizabeth Mills, Stephen Nazareth, Justin Nguyen, Kenya Ochoa, Sophie Robbins, Despoina Sparakis, Brian Ta, Kian Trengove, Tyler Xu, Natsuko Yamaguchi, Christine Yang, Eden Zafran, Aaron P. Blaisdell, Katsushi Arisaka
Visual perception plays a critical role in navigating 3D space and extracting semantic information crucial to survival. Even though visual stimulation on the retina is fundamentally 2D, we seem to perceive the world around us in vivid 3D effortlessly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac7ecb544833f7504c1f18330ff4a065
https://doi.org/10.1101/2022.02.28.482181
https://doi.org/10.1101/2022.02.28.482181
Autor:
Pranav Chandrashekar, Lana Rashdan, Zack Dale, Scott Warner, Sajan Gill, Yunwoo Burton, Babak Nazer, Ahmad Masri
Publikováno v:
Circulation. 144
Introduction: Due to conduction disease and dyssynchrony in transthyretin amyloid cardiomyopathy (ATTR-CM), cardiac resynchronization therapy (CRT) may be beneficial. We aimed to determine the impact of CRT on clinical outcomes in ATTR-CM. Methods: W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9111f93887bb99fe92e0741357e5d119
https://doi.org/10.1161/circ.144.suppl_1.13557
https://doi.org/10.1161/circ.144.suppl_1.13557
Publikováno v:
Heart failure reviews. 27(5)
The therapeutic landscape for cardiac amyloidosis is rapidly evolving. In the last decade, our focus has shifted from dealing with the inevitable complications of continued extracellular infiltration of amyloid fibrils to earlier identification of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2d86b611cf32f82684c8a6bf9d30a075
https://pubmed.ncbi.nlm.nih.gov/34783948
https://pubmed.ncbi.nlm.nih.gov/34783948
Autor:
Kevin M. Alexander, Laith Alhuneafat, Jason Dungu, Meghan Mannello, Pranav Chandrashekar, Ahmad Masri, Lana Al-Rashdan, Morris Kim
Publikováno v:
Circulation: Genomic and Precision Medicine. 14
Background: The p.Val142Ile variant, predominantly found among people of African descent, is the most common cause of variant transthyretin amyloidosis and carriers predominantly develop a cardiomyopathy (variant transthyretin amyloidosis cardiomyopa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdebea4690a01c53a6148c49edee1b25
https://doi.org/10.1161/circgen.121.003356
https://doi.org/10.1161/circgen.121.003356